Andre van Hoek
Direttore Finanziario/CFO presso Stalar 3, Inc.
Posizioni attive di Andre van Hoek
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Stalar 3, Inc.
 Stalar 3, Inc. Financial ConglomeratesFinance Stalar 3, Inc. operates as a blank check company with no significant operations. The company is formed to pursue a business combination with an operating private company, foreign & domestic, seeking to become a public company. The firm has been engaged in initial financing and has commenced negotiations with operating entities. It was founded on November 13, 2007 and is headquartered in New York, NY. | Direttore/Membro del Consiglio | 24/01/2011 | - |
| Direttore Finanziario/CFO | 24/01/2011 | - | |
Stalar 4, Inc.
 Stalar 4, Inc. Financial ConglomeratesFinance Stalar 4, Inc. operates as a blank check company with no significant operations. The company is formed to pursue a business combination with an operating private foreign or domestic company that is seeking to become a reporting public company. Stalar 4 was founded on November 13, 2007 and is headquartered in New York, NY. | Direttore/Membro del Consiglio | 25/01/2011 | - |
| Direttore Finanziario/CFO | 25/01/2011 | - |
Storia della carriera di Andre van Hoek
Precedenti posizioni note di Andre van Hoek
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CELGENE | Comptroller/Controller/Auditor | - | 30/06/2012 |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
Posizioni
| Director of Finance/CFO | 2 |
| Director/Board Member | 2 |
| Comptroller/Controller/Auditor | 1 |
Settori
| Finance | 3 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 3 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Stalar 3, Inc.
Stalar 3, Inc. Financial ConglomeratesFinance Stalar 3, Inc. operates as a blank check company with no significant operations. The company is formed to pursue a business combination with an operating private company, foreign & domestic, seeking to become a public company. The firm has been engaged in initial financing and has commenced negotiations with operating entities. It was founded on November 13, 2007 and is headquartered in New York, NY. | Finance |
Stalar 4, Inc.
Stalar 4, Inc. Financial ConglomeratesFinance Stalar 4, Inc. operates as a blank check company with no significant operations. The company is formed to pursue a business combination with an operating private foreign or domestic company that is seeking to become a reporting public company. Stalar 4 was founded on November 13, 2007 and is headquartered in New York, NY. | Finance |
- Borsa valori
- Insiders
- Andre van Hoek
- Esperienza
